Dr Amza Ali is a neurologist and epileptologist with a career-long commitment to advocacy for people with epilepsy and a particular interest in research at the intersection of Neurology and Business, focusing on healthcare innovation for low-middle income countries.
He holds an MBA from the University of Toronto and has significant C-suit
Dr Amza Ali is a neurologist and epileptologist with a career-long commitment to advocacy for people with epilepsy and a particular interest in research at the intersection of Neurology and Business, focusing on healthcare innovation for low-middle income countries.
He holds an MBA from the University of Toronto and has significant C-suite experience in the Canadian biotechnology corporate sector.
His work has received recognition from major centres and institutions globally, including the Royal Colleges of Physicians of the UK, the American Academy of Neurology and Yale University. He was conferred the ILAE-IBE Lifetime Ambassador for Epilepsy Award in 2019.
Dr André Fenton is a Professor and Chair of Neural Science at New York University.
André founded Bio-Signal Group Corp., which develops and sells a portable, wireless, and easy-to-use platform for recording EEGs in novel medical applications. André is an inventor with experience operating in both the best resourced and also poorly resourc
Dr André Fenton is a Professor and Chair of Neural Science at New York University.
André founded Bio-Signal Group Corp., which develops and sells a portable, wireless, and easy-to-use platform for recording EEGs in novel medical applications. André is an inventor with experience operating in both the best resourced and also poorly resourced medical settings, and has invented numerous medical and information technologies that enable easy to use, high-quality EEG at low cost for use by anyone anywhere. André advises the US National Institute of Mental Health Leadership as Chair of the Board of Scientific Councilors
Dr Carlen is a Professor of Medicine (Neurology), Physiology, and Biomedical Engineering at the University of Toronto. He is also an active neurological clinician at the University Health Network with a practice focused mainly on patients with epilepsy
He was formerly the Head of Neurology at the Addiction Research Foundation and Director
Dr Carlen is a Professor of Medicine (Neurology), Physiology, and Biomedical Engineering at the University of Toronto. He is also an active neurological clinician at the University Health Network with a practice focused mainly on patients with epilepsy
He was formerly the Head of Neurology at the Addiction Research Foundation and Director of Neuroscience Research at the University Health Network, where he is now a Senior Clinician/Scientist.
His main research interests are mechanisms and pharmacology of epilepsy, sudden unexpected death in epilepsy (SUDEP), EEG brain state classification, and using human cerebral organoids to study neurological disorders, particularly epilepsy.
Justin Grant
Dr. Justin Grant has a PhD in Pharmaceutical Sciences with expertise in drug development at Canada’s top research institutes and early-stage biotech companies. Dr. Grant completed his MBA to bridge the gap between science and business to advance innovative therapies. Justin has many years of executive-level experience in ea
Justin Grant
Dr. Justin Grant has a PhD in Pharmaceutical Sciences with expertise in drug development at Canada’s top research institutes and early-stage biotech companies. Dr. Grant completed his MBA to bridge the gap between science and business to advance innovative therapies. Justin has many years of executive-level experience in early-stage companies that focus on bringing innovative healthcare technologies to the market. Justin is particularly interested in addressing the gap in healthcare to find more efficient and sustainable solutions in lower resourced environments including the Caribbean, Europe and North America.
Dr. Hofstein is a professional expert in the development of healthcare technologies encompassing medical diagnostics, medical devices, therapeutics and health-IT. Dr. Hofstein incorporated and managed MaRSInnovation, a prestigious technology transfer company representing the majority of healthcare related research in Ontario, Canada.
Rawn Lakhan has over 20 years’ experience in the financial services industry, including portfolio management and investment banking. He is currently CEO and co-founder of Meadowbank Asset Management, a portfolio manager and exempt market dealer since 2006.
Copyright © 2024 Episteme Partners - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.